Key result
The TandemHeart percutaneous left ventricular assist device was easily and rapidly deployed in 6 patients during emergency or elective high-risk PCI to achieve complete cardiac assistance.
Why the study?
Is the percutaneous left ventricular assist device feasible for complete cardiac assistance during high-risk percutaneous coronary interventions?
Observational (n=6)
No
Is the percutaneous left ventricular assist device feasible for complete cardiac assistance during high-risk percutaneous coronary interventions?
Answers are grounded in this paper and cite their sources.
The percutaneous left ventricular assist device is feasible for rapid deployment to provide complete circulatory support during high-risk percutaneous coronary interventions.
Patients with severe depression of left ventricular ejection fraction and high-risk coronary lesions are at risk of developing complications during percutaneous coronary interventions (PCI). Intra-aortic balloon pump (IABP) is a support that helps the interventionalist in such hemodynamic complications during high-risk PCI, but it does not offer complete circulatory support. Instead, TandemHeart (Cardiac Assist, Pittsburg, PA, USA) is a percutaneous left ventricular assist device (pLVAD) that gives total left circulatory support and can be used for patients in cardiogenic shock or for elective PCI at high-risk. TandemHeart is a percutaneous transseptal ventricular assist device that allows a rapid percutaneous left ventricular support without the need for surgical implantation. Between November 2003 and April 2005, 6 patients admitted to our coronary care unit (CCU) underwent either emergency (n = 3) or elective (n = 3) placement of the TandemHeart device before a high-risk procedure. From our initial experience we conclude that the percutaneous transseptal ventricular assist device, TandemHeart, can be easily and rapidly deployed either in emergency or in elective high-risk PCI to achieve complete cardiac assistance.
No takes yet. Share an insight, caveat, or question.
Giombolini et al. (2006) conducted an observational in High-risk percutaneous coronary interventions (n=6). TandemHeart percutaneous left ventricular assist device was evaluated on Feasibility of deployment and complete cardiac assistance. The TandemHeart percutaneous left ventricular assist device was easily and rapidly deployed in 6 patients during emergency or elective high-risk PCI to achieve complete cardiac assistance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: